Covered recipient · General Payments record
JAMES R ARNOLD
Podiatric Medicine & Surgery Service Providers Podiatrist
General Payments · PY2018–2024
$4,239.37
- Reported across 100 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,008.12 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Smith & Nephew, Inc. | $303.42 | 5 |
| Kerecis Limited | $223.77 | 1 |
| IBSA Pharma Inc. | $125.00 | 1 |
| Medtronic, Inc. | $105.51 | 1 |
| LifeNet Health | $104.22 | 1 |
| Stryker Corporation | $57.72 | 2 |
| ORGANOGENESIS INC. | $26.03 | 1 |
| Pacira Pharmaceuticals Incorporated | $24.57 | 1 |
| Nevro Corp. | $19.99 | 1 |
| Paratek Pharmaceuticals, Inc. | $17.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| IBSA Pharma Inc. | $125.00 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142976988 | CMS |
| Kerecis Limited | $223.77 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120117844 | CMS |
| LifeNet Health | $104.22 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153023166 | CMS |
| Medtronic, Inc. | $105.51 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119465637 | CMS |
| Nevro Corp. | $19.99 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130730151 | CMS |
| Organogenesis Inc. | $26.03 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145416727 | CMS |
| Pacira Pharmaceuticals Incorporated | $24.57 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151247357 | CMS |
| Paratek Pharmaceuticals, Inc. | $17.89 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113891440 | CMS |
| Smith+Nephew, Inc. | $13.84 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149514055 | CMS |
| Smith+Nephew, Inc. | $10.57 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149514053 | CMS |
| Smith+Nephew, Inc. | $139.85 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149514061 | CMS |
| Smith+Nephew, Inc. | $38.46 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149514057 | CMS |
| Smith+Nephew, Inc. | $100.70 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149514059 | CMS |
| Stryker Corporation | $43.71 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119764394 | CMS |
| Stryker Corporation | $14.01 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119764396 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.